These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4111694)

  • 1. Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP.
    Dumonde DC; Page DA; Matthew M; Wolstencroft RA
    Clin Exp Immunol; 1972 Jan; 10(1):25-47. PubMed ID: 4111694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytophilic activity of IgG2 from sera of guinea-pigs immunized with bovine gamma-globulin.
    Leslie RG; Cohen S
    Immunology; 1974 Oct; 27(4):589-99. PubMed ID: 4140145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the macrophage migration inhibition test to monitor fractionation of soluble antigens of chemically induced sarcomas of inbred guinea pigs.
    Suter L; Bloom BR; Wadsworth EM; Oettgen HF
    J Immunol; 1972 Oct; 109(4):766-75. PubMed ID: 5074331
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular hypersensitivity: the production of antibody by cultures of lymphocytes producing macrophage inhibitory factor.
    Meyers OL; Shoji M; Haber E; Remold HG; David JR
    Cell Immunol; 1972 Mar; 3(3):442-7. PubMed ID: 4111124
    [No Abstract]   [Full Text] [Related]  

  • 5. Staphylococcal enterotoxin B induced release of macrophage migration inhibition factor from normal lymphocytes.
    Kaplan J
    Cell Immunol; 1972 Feb; 3(2):245-52. PubMed ID: 4110889
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation.
    Kelly RH; Wolstencroft RA; Dumonde DC; Balfour BM
    Clin Exp Immunol; 1972 Jan; 10(1):49-65. PubMed ID: 4111695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and properties of a lymphocyte inhibition factor from human serum.
    Ford WH; Caspary EA; Shenton B
    Clin Exp Immunol; 1973 Oct; 15(2):169-79. PubMed ID: 4762015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.
    Remold HG; David RA; David JR
    J Immunol; 1972 Sep; 109(3):578-86. PubMed ID: 4115544
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.
    David JR; Coyne JA; Rocklin RE; Nathan CF; Remold HG
    Transplant Proc; 1972 Jun; 4(2):241-2. PubMed ID: 4113698
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of guinea-pig antisera to sheep IgM and slow and fast gamma-globulins.
    Jonas WE
    Res Vet Sci; 1971 Jan; 12(1):23-9. PubMed ID: 4102566
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental allergic encephalitis: study of cellular immunity to the encephalitogenic determinant.
    Spitler LE; von Muller CM; Young JD
    Cell Immunol; 1975 Jan; 15(1):143-51. PubMed ID: 45837
    [No Abstract]   [Full Text] [Related]  

  • 12. Local and systemic cellular immune responses in guinea-pigs given antigen parenterally or directly into the lower respiratory tract.
    Nash DR; Holle B
    Clin Exp Immunol; 1973 Apr; 13(4):573-83. PubMed ID: 4123822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes.
    Torisu M; Yoshida T; Ward PA; Cohen S
    J Immunol; 1973 Nov; 111(5):1450-8. PubMed ID: 4126774
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes.
    Simon HB; Sheagren JN
    Cell Immunol; 1972 Jun; 4(2):163-74. PubMed ID: 4112849
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis.
    Remold HG; Katz AB; Haber E; David JR
    Cell Immunol; 1970 May; 1(1):133-45. PubMed ID: 4108779
    [No Abstract]   [Full Text] [Related]  

  • 16. Migration inhibition response of mononuclear cells mediating granulomatous inflammation.
    Galindo B; Heise ER; Myrvik QN
    Ser Haematol; 1970; 3(2):145-59. PubMed ID: 4108765
    [No Abstract]   [Full Text] [Related]  

  • 17. Guinea-pig reaginic antibody. I. Isolation and purification of an antibody protein with characteristics of IgE.
    Margni RA; Hajos SE
    Immunology; 1973 Aug; 25(2):323-32. PubMed ID: 4126261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine immunoglobulins. II. Antibody response of adult swine to bovine globulin.
    Kaltreider HB; Johnson JS
    J Immunol; 1972 Nov; 109(5):999-1002. PubMed ID: 4116767
    [No Abstract]   [Full Text] [Related]  

  • 19. The allogeneic effect: increased cellular immune and inflammatory responses.
    Elfenbein GJ; Green I; Paul WE
    J Immunol; 1974 Jun; 112(6):2166-75. PubMed ID: 4133079
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity.
    Yoshida T; Cohen S
    J Immunol; 1974 Apr; 112(4):1540-7. PubMed ID: 4131167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.